Inger Helene Mattsby Baltzer

Fungea AB engages in the development of tests to detect the presence of fungi, bacteria, or other microorganisms in humans and animals, food ingredients, or elsewhere in the environment. It specializes in commercial physical and biological research. The firm also develops probiotics and other methods to influence the microbial environment, production, and distribution of its products and consulting. The company was founded on June 19, 2006 and is headquartered in Nödinge, Sweden.

PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established.